G.Barekat Pharm (XTEH:BRKT1) Total Payout Ratio : 0.00 (As of May. 15, 2024)

View and export this data going back to 2017. Start your Free Trial

What is G.Barekat Pharm Total Payout Ratio?

Total Payout Ratio is the percent a company has paid to its shareholders through net repurchase of shares and dividends based on its Net Income.

G.Barekat Pharm's current Total Payout Ratio is 0.00.

G.Barekat Pharm Total Payout Ratio Historical Data

The historical data trend for G.Barekat Pharm's Total Payout Ratio can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

G.Barekat Pharm Total Payout Ratio Chart

G.Barekat Pharm Annual Data

Trend

Mar16

Mar17

Total Payout Ratio

G.Barekat Pharm Semi-Annual Data
	Mar16	Mar17
Total Payout Ratio	-	-

Competitive Comparison of G.Barekat Pharm's Total Payout Ratio

For the Biotechnology subindustry, G.Barekat Pharm's Total Payout Ratio, along with its competitors' market caps and Total Payout Ratio data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

G.Barekat Pharm's Total Payout Ratio Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, G.Barekat Pharm's Total Payout Ratio distribution charts can be found below:

* The bar in red indicates where G.Barekat Pharm's Total Payout Ratio falls into.

G.Barekat Pharm Total Payout Ratio Calculation

Total Payout Ratio is a measurement showing the proportion of earnings a company pays shareholders in the form of dividends and net stock repurchases.

G.Barekat Pharm's Total Payout Ratio for the fiscal year that ended in Mar. 2017 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	3706833
	=	0.00

G.Barekat Pharm's Total Payout Ratio for the quarter that ended in Mar. 2017 is calculated as

Total Payout Ratio	=	- (Repurchase of Stock	+	Issuance of Stock	+	Cash Flow for Dividends)	/	Net Income
	=	- (0	+	0	+	0)	/	3706833
	=	0.00

G.Barekat Pharm Total Payout Ratio Related Terms

Thank you for viewing the detailed overview of G.Barekat Pharm's Total Payout Ratio provided by GuruFocus.com. Please click on the following links to see related term pages.

G.Barekat Pharm (XTEH:BRKT1) Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » G.Barekat Pharm (XTEH:BRKT1) » Definitions » Total Payout Ratio

Comparable Companies

Traded in Other Exchanges

N/A

Address

No. 11, 5th Alley, Bucharest Avenue, Argentina Square, Tehran, IRN

Website

http://www.bpharmed.com

G.Barekat Pharm focuses on the introduction of new pharmaceutical fields such as biotechnology, drug delivery which includes nanotechnology, slow release drugs, and new technologies for health, development of cellular molecular industries like tuberculosis, gene therapy, immunotherapy, and tissue technology.

G.Barekat Pharm (XTEH:BRKT1) Headlines

No Headlines